Laura López-Cruz

Laura López-Cruz

Auto-generated profile, based on publicly available information

Laura López-Cruz

Department of Psychology and MRC/Wellcome Trust Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2016 in Brain
Verified
Journal Article
Open access
PDF file
JSJohn D. Salamone
John D. Salamone
SYSamantha E. Yohn
Samantha E. Yohn
LLLaura López-Cruz
Laura López-Cruz
NMNoemí San Miguel
Noemí San Miguel
MCMercè Correa
Mercè Correa
Motivation has been defined as the process that allows organisms to regulate their internal and external environment, and control the probability, proximity and availability of stimuli. As such, motivation is a complex process that is critical for survival, which involves multiple behavioural functions mediated by a number of interacting neural circuits. Classical theories of motivation suggest that there are both directional and activational aspects of motivation, and activational aspects (i.e. speed and vigour of both the instigation and persistence of behaviour) are critical for enabling organisms to overcome work-related obstacles or constraints that separate them from significant stimuli. The present review discusses the role of brain dopamine and related circuits in behavioural activation, exertion of effort in instrumental behaviour, and effort-related decision-making, based upon both animal and human studies. Impairments in behavioural activation and effort-related aspects of motivation are associated with psychiatric symptoms such as anergia, fatigue, lassitude and psychomotor retardation, which cross multiple pathologies, including depression, schizophrenia, and Parkinson’s disease. Therefore, this review also attempts to provide an interdisciplinary approach that integrates findings from basic behavioural neuroscience, behavioural economics, clinical neuropsychology, psychiatry, and neurology, to provide a coherent framework for future research and theory in this critical field. Although dopamine systems are a critical part of the brain circuitry regulating behavioural activation, exertion of effort, and effort-related decision-making, mesolimbic dopamine is only one part of a distributed circuitry that includes multiple neurotransmitters and brain areas. Overall, there is a striking similarity between the brain areas involved in behavioural activation and effort-related processes in rodents and in humans. Animal models of effort-related decision-making are highly translatable to humans, and an emerging body of evidence indicates that alterations in effort-based decision-making are evident in several psychiatric and neurological disorders. People with major depression, schizophrenia, and Parkinson’s disease show evidence of decision-making biases towards a lower exertion of effort. Translational studies linking research with animal models, human volunteers, and clinical populations are greatly expanding our knowledge about the neural basis of effort-related motivational dysfunction, and it is hoped that this research will ultimately lead to improved treatment for motivational and psychomotor symptoms in psychiatry and neurology.

1 September 2015
Verified
Book Chapter
Closed access
PDF file
JSJohn D. Salamone
John D. Salamone
MPMarta Pardo
Marta Pardo
SYSamantha E. Yohn
Samantha E. Yohn
LLLaura López-Cruz
Laura López-Cruz
NSNoemí SanMiguel
Noemí SanMiguel
MCMercè Correa
Mercè Correa

22 October 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PRPatrick A. Randall
Patrick A. Randall
MPMarta Pardo
Marta Pardo
ENEric J. Nunes
Eric J. Nunes
LCLaura López Cruz
Laura López Cruz
VVV. Kiran Vemuri
V. Kiran Vemuri
JSJohn D. Salamone
John D. Salamone
Mesolimbic dopamine (DA) is involved in behavioral activation and effort-related processes. Rats with impaired DA transmission reallocate their instrumental behavior away from food-reinforced tasks with high response requirements, and instead select less effortful food-seeking behaviors. In the present study, the effects of several drug treatments were assessed using a progressive ratio (PROG)/chow feeding concurrent choice task. With this task, rats can lever press on a PROG schedule reinforced by a preferred high-carbohydrate food pellet, or alternatively approach and consume the less-preferred but concurrently available laboratory chow. Rats pass through each ratio level 15 times, after which the ratio requirement is incremented by one additional response. The DA D2 antagonist haloperidol (0.025–0.1 mg/kg) reduced number of lever presses and highest ratio achieved but did not reduce chow intake. In contrast, the adenosine A2A antagonist MSX-3 increased lever presses and highest ratio achieved, but decreased chow consumption. The cannabinoid CB1 inverse agonist and putative appetite suppressant AM251 decreased lever presses, highest ratio achieved, and chow intake; this effect was similar to that produced by pre-feeding. Furthermore, DA-related signal transduction activity (pDARPP-32(Thr34) expression) was greater in nucleus accumbens core of high responders (rats with high lever pressing output) compared to low responders. Thus, the effects of DA antagonism differed greatly from those produced by pre-feeding or reduced CB1 transmission, and it appears unlikely that haloperidol reduces PROG responding because of a general reduction in primary food motivation or the unconditioned reinforcing properties of food. Furthermore, accumbens core signal transduction activity is related to individual differences in work output.

4 December 2013 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
ENEric J. Nunes
Eric J. Nunes
PRPatrick A. Randall
Patrick A. Randall
EHEvan E. Hart
Evan E. Hart
CFCharlotte Freeland
Charlotte Freeland
SYSamantha E. Yohn
Samantha E. Yohn
JSJohn D. Salamone
John D. Salamone
Motivated behaviors are often characterized by a high degree of behavioral activation, and work output and organisms frequently make effort-related decisions based upon cost/benefit analyses. Moreover, people with major depression and other disorders often show effort-related motivational symptoms such as anergia, psychomotor retardation, and fatigue. It has been suggested that tasks measuring effort-related choice behavior could be used as animal models of the motivational symptoms of depression, and the present studies characterized the effort-related effects of the vesicular monoamine transport (VMAT) inhibitor tetrabenazine. Tetrabenazine produces depressive symptoms in humans and, because of its selective inhibition of VMAT-2, it preferentially depletes dopamine (DA). Rats were assessed using a concurrent fixed-ratio 5/chow feeding choice task that is known to be sensitive to dopaminergic manipulations. Tetrabenazine shifted response choice in rats, producing a dose-related decrease in lever pressing and a concomitant increase in chow intake. However, it did not alter food intake or preference in parallel free-feeding choice studies. The effects of tetrabenazine on effort-related choice were reversed by the adenosine A2Aantagonist MSX-3 and the antidepressant bupropion. A behaviorally active dose of tetrabenazine decreased extracellular DA in nucleus accumbens and increased expression of DARPP-32 in accumbens medium spiny neurons in a pattern indicative of reduced transmission at both D1and D2DA receptors. These experiments demonstrate that tetrabenazine, which is used in animal models to produce depression-like effects, can alter effort-related choice behavior. These studies have implications for the development of animal models of the motivational symptoms of depression and related disorders.

1 April 2012 in Neuropharmacology
Verified
Journal Article
Closed access
MPM. Pardo
M. Pardo
LLL. Lopez-Cruz
L. Lopez-Cruz
OVO. Valverde
O. Valverde
CLC. Ledent
C. Ledent
Younis BaqiYounis Baqi
Younis Baqi
MCM. Correa
M. Correa

1 June 2016 in Behavioural Processes
Verified
Journal Article
Closed access
JSJohn D. Salamone
John D. Salamone
MCMerce Correa
Merce Correa
SYSamantha Yohn
Samantha Yohn
LCLaura Lopez Cruz
Laura Lopez Cruz
NMNoemi San Miguel
Noemi San Miguel
LALuisa Alatorre
Luisa Alatorre